Travere Therapeutics
TVTX
TVTX
147 hedge funds and large institutions have $1.48B invested in Travere Therapeutics in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 43 increasing their positions, 53 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
9% more funds holding
Funds holding: 135 → 147 (+12)
1.06% less ownership
Funds ownership: 101.32% → 100.25% (-1.1%)
19% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 53
Holders
147
Holding in Top 10
4
Calls
$6.19M
Puts
$5.08M
Top Buyers
| 1 | +$44.9M | |
| 2 | +$42M | |
| 3 | +$18.9M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$10.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.75M |
Top Sellers
| 1 | -$45.9M | |
| 2 | -$33.1M | |
| 3 | -$24.3M | |
| 4 |
D.E. Shaw & Co
New York
|
-$19.2M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$17.4M |